Understanding the Differences between Arcapta Neohaler and Indacaterol

 



Chronic obstructive pulmonary disease (COPD) is a progressive and debilitating condition that affects millions of people worldwide. COPD patients experience difficulty breathing due to the narrowing of their airways, and this can lead to severe breathing problems and even death. There are several medications available to treat COPD, and two of the most commonly prescribed drugs are Arcapta Neohaler and Indacaterol.

Arcapta Neohaler and Indacaterol are both long-acting beta-agonists (LABAs) that work by relaxing the muscles around the airways, making it easier to breathe. However, there are some significant differences between the two drugs.

Active Ingredients:

Arcapta Neohaler is a brand name for the active ingredient indacaterol maleate, while Indacaterol is the generic name for the same active ingredient. Therefore, both medications contain the same active ingredient, but Arcapta Neohaler is a branded medication, while Indacaterol is the generic version.

Dosage and Administration:

The dosage and administration of both Arcapta Neohaler and Indacaterol are very similar. They are both taken once daily, and the recommended dose is one inhalation per day. However, the inhaler devices used for the two drugs are different. Arcapta Neohaler is a dry powder inhaler, while Indacaterol is available as a solution for inhalation.

Indications:

Both Arcapta Neohaler and Indacaterol are used for the long-term treatment of COPD. They are both indicated to improve symptoms of COPD, such as shortness of breath, cough, and wheezing. However, Arcapta Neohaler is only approved for the maintenance treatment of COPD, while Indacaterol is also indicated for the treatment of asthma in patients aged 12 years and older.

Efficacy:

The efficacy of both drugs has been demonstrated in clinical studies. In a 12-week study, Arcapta Neohaler was shown to significantly improve lung function and reduce shortness of breath in patients with COPD. In another study, Indacaterol was shown to significantly improve lung function and reduce the frequency of exacerbations in patients with COPD.

Side Effects:

Both Arcapta Neohaler and Indacaterol can cause side effects. The most common side effects of Arcapta Neohaler are headache, back pain, cough, and nausea. The most common side effects of Indacaterol are headache, nausea, and nasopharyngitis. However, both medications are generally well-tolerated, and serious side effects are rare.

Cost:

One of the biggest differences between Arcapta Neohaler and Indacaterol is the cost. Arcapta Neohaler is a branded medication, and as such, it is more expensive than Indacaterol, which is a generic medication. The cost difference can be significant, and this may be an important consideration for patients who need to take these medications long-term.
(Suggestion: Purchasing Arcapta Neohaler (Indacaterol) Inhaler from LifeRX Pharmacy is the Best Option. On LifeRX Pharmacy You can Get Greate Discount Coupons.)

In conclusion, both Arcapta Neohaler and Indacaterol are effective medications for the treatment of COPD. They both contain the same active ingredient and are similarly effective in improving lung function and reducing symptoms of COPD. However, there are some differences between the two medications, such as their dosage and administration, indications, and cost, which may be important factors to consider when choosing the appropriate treatment for COPD. Patients should discuss these options with their healthcare providers to determine the best course of treatment for their individual needs.
Click below to Check the Price

Comments

Popular posts from this blog

Exploring Brilinta Coupon Options and Understanding the Cost of this Heart Medication

What is Januvia and How Much Does Januvia Cost?

Saving Money on Trelegy Ellipta: How to Use Meds Engage Coupons and Other Cost-Saving Options